Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Neoplasms 2Melanoma 2Hematologic Neoplasms 2Febrile Neutropenia 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Pancreatic Neoplasms 1Neutropenia 1Neoplasm Metastasis 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Hematologic Diseases 1Early Stage Non-Small Cell Lung Cancer 1Clostridium Infections 1Breast Neoplasms 1

Interventions

Vancomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clostridium Infections × Vancomycin × 1 year × Clear all
NCT03030248 2026-04-15

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Medical College of Wisconsin

Phase 2 Completed
9 enrolled 9 charts

Clostridium Infections, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡